AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
DAPOXETINE
25 registrations across 6 African markets— 15 active
Markets with DAPOXETINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| DAPOXEM 30 TABLET, COATED; ORAL | 🇿🇼Zimbabwe | MSN LABORATORIES LTD | active | Aug 2029 |
| LONGRIDE TABLET, COATED; ORAL | 🇿🇼Zimbabwe | MSN LABORATORIES LTD | active | Aug 2029 |
| DOXENDA Comprimé pelliculé / 30 mg | 🇹🇳Tunisia | IBN AL BAYTAR | expired | Oct 2022 |
| DOXENDA Comprimé pelliculé / 60 mg | 🇹🇳Tunisia | IBN AL BAYTAR | expired | Oct 2022 |
| PRILIGY Comprimé pelliculé / 60 mg | 🇹🇳Tunisia | MENARINI Ind.Farmaceutiche Internazionale SRL | expired | Jun 2022 |
| PRILIGY Comprimé pelliculé / 30 mg | 🇹🇳Tunisia | MENARINI Ind.Farmaceutiche Internazionale SRL | expired | Jun 2022 |
| PRILIGY 30MG TABLETS 1 X 3'S | 🇳🇬Nigeria | PHILIPS PHARM. NIG. LTD. | expired | Mar 2022 |
| PRILIGY 60MG TABLETS 1 X 3'S | 🇳🇬Nigeria | PHILIPS PHARM. NIG. LTD. | expired | Mar 2022 |
| DAPOX Comprimé pelliculé / 30 mg | 🇹🇳Tunisia | TERIAK | expired | Sept 2021 |
| DAPOX Comprimé pelliculé / 60 mg | 🇹🇳Tunisia | TERIAK | expired | Sept 2021 |
| DAPOX Comprimé pelliculé / 60 mg | 🇹🇳Tunisia | TERIAK | expired | Sept 2021 |
| DAPOX Comprimé pelliculé / 30 mg | 🇹🇳Tunisia | TERIAK | expired | Sept 2021 |
| PRILIGY 30 mg | 🇿🇦South Africa | LeBasi Pharmaceuticals (Pty) Ltd | active | Jan 1900 |
| PRILIGY 60 mg | 🇿🇦South Africa | LeBasi Pharmaceuticals (Pty) Ltd | active | Jan 1900 |
| DAPOXETINE ORAL SOLID
ORDINARY FILM-
COATED
TABLETS | 🇺🇬Uganda | MSN LABORATORIES PRIVATE LIMITED | active | — |
| PRILIGY comprimé pelliculé / 30 mg | 🇸🇳Senegal | MENARINI | active | — |
| PRILIGY comprimé pelliculé / 60 mg | 🇸🇳Senegal | A MENARINI INDUSTRIE FARMACEUTICHE | active | — |
| DAPOXETINE ORAL SOLID
ORDINARY FILM-
COATED TABLETS | 🇺🇬Uganda | MSN LABORATORIES PRIVATE LIMITED | active | — |
| EVITOP comprimé pelliculé / 60 mg | 🇸🇳Senegal | WEST AFRIC PHARMA | active | — |
| PRILIGY comprimé pelliculé / 60 mg | 🇸🇳Senegal | A MENARINI INDUSTRIE FARMACEUTICHE | active | — |
| DAPOXETINE ORAL SOLID
ORDINARY FILM-
COATED TABLETS | 🇺🇬Uganda | MSN LABORATORIES PRIVATE LIMITED | active | — |
| DAPOX-GH comprime / 60 mg | 🇸🇳Senegal | GENERIC HEALTH CARE PVT. LTD | active | — |
| EVITOP comprimé pelliculé / 30 mg | 🇸🇳Senegal | WEST AFRIC PHARMA | active | — |
| DAPOX-GH comprimé enrobé / 30 mg | 🇸🇳Senegal | GENERIC HEALTHCARE PVT. LTD | active | — |
| DAPOXETINE ORAL SOLID
ORDINARY FILM-
COATED
TABLETS | 🇺🇬Uganda | MSN LABORATORIES PRIVATE LIMITED | active | — |
DAPOXETINE in Africa — Regulatory Overview
DAPOXETINE is registered across 6 African markets with 25 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Senegal, Uganda, Nigeria and 2 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 25 registrations, 15 (60%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.